Serum PD-1 levels measured by ELISA using Nivolumab increased in advanced RCC patients: novel approach to develop companion diagnostics for antibody therapy

Detalles Bibliográficos
Autores principales: Mizutani, Kosuke, Horie, Kengo, Kato, Taku, Nakane, Keita, Kawakami, Kyojiro, Fujita, Yasunori, Ito, Masafumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Letter to the Editors
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6527537/
https://www.ncbi.nlm.nih.gov/pubmed/30515569
http://dx.doi.org/10.1007/s00432-018-2806-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6527537/
https://www.ncbi.nlm.nih.gov/pubmed/30515569
http://dx.doi.org/10.1007/s00432-018-2806-2

Ejemplares similares